About
Exit071 develops proprietary microfluidic technology for isolating and analyzing extracellular vesicles (exosomes), enabling high-resolution biomarker discovery and accelerating drug development workflows.
Explore Exit071's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.